With grey areas aplenty, India's marketing code in autopilot?
This article was originally published in Scrip
Ambiguities in India's new Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) appear to have stretched early compliance deadlines via autopilot mode.
You may also be interested in...
India's uniform code for pharmaceuticals marketing practices, so far voluntary in nature, appears to be on course to becoming "statutory" and "mandatory", signaling some potential short-term turbulence in the growing domestic market.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.